Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado Yale University, New Haven, Connecticut Mount Sinai Medical Center, Miami Beach, Florida Florida Cancer Specialists, Sarasota, Florida Dana Farber Cancer Institute, Boston, Massachusetts